Despite advanced medical treatments extending survival rates for hepatocellular carcinoma (HCC) patients in many developed countries, significant challenges persist in Thailand, even with the Universal Coverage Scheme. In Thailand, HCC is the most common cancer and the leading cause of cancer-related mortality. A critical issue is that socioeconomic status significantly affects survival, highlighting disparities in patient care and treatment access. Limited healthcare resources in the country
Conditions
Interventions
Participants must be classified as an HCC survivor which is defined as a patient who has lived for more than one year post-HCC diagnosis
Health Services Research
Hepatocellular survivor
Sponsors
Roche(Thailand)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Participants must be patients diagnosed with hepatocellular carcinoma .2.Participants must be classified as an HCC survivor which is defined as a patient who has lived for more than one year post-HCC diagnosis 3. Participants must be attending routine follow-up appointments at the outpatient clinics of the participating hospitals. 4. Informed consent must be obtained from all individual participants included in the study.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Financial perspective more than one year post-HCC diagnosis bath | — |
Secondary
| Measure | Time frame |
|---|---|
| social dimension more than one year post-HCC diagnosis social support | — |
Countries
Thailand
Contacts
Public ContactPassakorn Wanchaijiraboon
Phrapokklao Hospital
Outcome results
None listed